MEDGENICS INC WT PUR COM EXP 03/31/16
MDGN.WS
MDGN.WS was delisted on the 7th of April, 2016.
1 hedge funds and large institutions have $1.11M invested in MEDGENICS INC WT PUR COM EXP 03/31/16 in 2014 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 1 closing their positions.
18% more capital invested
Capital invested by funds: $941K → $1.11M (+$172K)
50% less funds holding
Funds holding: 2 → 1 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$35.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
U
UBS
Zurich,
Switzerland
|
-$1K |
MDGN.WS Hedge Fund Activity: Q2 2014 in Review
1 of the 3,480 institutional investors tracked by Wall St. Rank reported a position in MEDGENICS INC WT PUR COM EXP 03/31/16 (MDGN.WS) for Q2 2014, worth a combined $1.11M — up 18% from $941K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of MDGN.WS and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 1 added.
The largest buyer was Sabby Management, adding an estimated $35.4K. The largest seller was UBS, exiting entirely with an estimated $1K sold.
- 1 institutional investor held MEDGENICS INC WT PUR COM EXP 03/31/16 (MDGN.WS) as of Q2 2014, down from 2 in Q1 2014.
- Funds reported $1.11M of MEDGENICS INC WT PUR COM EXP 03/31/16 stock for Q2 2014, up 18% quarter-over-quarter.
- 0 funds opened new MEDGENICS INC WT PUR COM EXP 03/31/16 positions in Q2 2014 and 1 closed out, a net change of -1 holder.
- The largest MEDGENICS INC WT PUR COM EXP 03/31/16 buyer in Q2 2014 was Sabby Management, an estimated $35.4K added.
- The largest MEDGENICS INC WT PUR COM EXP 03/31/16 seller in Q2 2014 was UBS, an estimated $1K sold.
Based on aggregated 13F filings for Q2 2014.